Invesco Ltd. Argenx Se Transaction History
Invesco Ltd.
- $557 Billion
- Q2 2025
A detailed history of Invesco Ltd. transactions in Argenx Se stock. As of the latest transaction made, Invesco Ltd. holds 243,746 shares of ARGX stock, worth $155 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
243,746
Previous 382,741
36.32%
Holding current value
$155 Million
Previous $227 Million
40.69%
% of portfolio
0.02%
Previous 0.04%
Shares
26 transactions
Others Institutions Holding ARGX
# of Institutions
493Shares Held
28.6MCall Options Held
376KPut Options Held
215K-
Price T Rowe Associates Inc Baltimore, MD4.98MShares$3.18 Billion0.31% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI2.79MShares$1.78 Billion2.84% of portfolio
-
Janus Henderson Group PLC London, X02.57MShares$1.64 Billion0.73% of portfolio
-
Capital World Investors Los Angeles, CA1.95MShares$1.24 Billion0.16% of portfolio
-
Avoro Capital Advisors LLC New York, NY1.18MShares$749 Million11.81% of portfolio
About ARGENX SE
- Ticker ARGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,323,800
- Market Cap $35.3B
- Description
- argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...